Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors

Breast Cancer Research and Treatment

Volumn 107, Issue 2, 2008, Pages 259-265

  Ellsworth, Rachel E ^a   Hooke, Jeffrey A ^b   Love, Brad ^c   Kane, Jennifer L ^a   Patney, Heather L ^a   Ellsworth, Darrell L ^a   Shriver, Craig D ^b  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c INVITROGEN CORPORATION   (United States)

Author keywords

Allelic imbalance; Grade; Invasive breast cancer

Indexed keywords

ACCURACY; ADULT; ALLELIC IMBALANCE; ARTICLE; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 9P; CHROMOSOME DELETION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETICS; GENOMIC INSTABILITY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICRODISSECTION; PRIORITY JOURNAL;

ALLELIC IMBALANCE; BREAST NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; CHROMOSOME MAPPING; FEMALE; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; NEOPLASM INVASIVENESS; PHYSICAL CHROMOSOME MAPPING; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; TREATMENT OUTCOME;

EID: 37249049293     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9547-2     Document Type: Article

References (20)

1. Millis RR et al (1998) Tumor grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34:548-553
2. Roylance R et al (2002) Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways. J Pathol 196:32-36
3. Roylance R et al (1999) Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 59:1433-1436
4. Buerger H et al (2001) Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 194(2):165-170
5. Sotiriou C et al (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4):262-272
6. Henson DE et al (1991) Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. Cancer 68(10):2142-2149
7. Elston CW, Ellis IO (1998) Systemic pathology 3E. In: Elston CW, Ellis IO (eds) The breast. Churchill Livingstone, Edinburgh pp. 3-10
8. American Joint Committee on Cancer. 2002. AJCC Cancer Staging Manual. 6 ed. Greene FL et al (eds). New York: Springer
9. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377
10. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19:403-410
11. Ellsworth DL et al (2003a) Laser capture microdissection of paraffin-embedded tissues. Biotechniques 34(1):42-46
12. Ellsworth RE et al (2003b) High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev 12(9):915-919
13. Medintz IL et al (2000) Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res 10:1211-1218
14. Ellsworth RE et al (2005) Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes. Mol Cancer Res 3:71-77
15. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759-767
16. Cleton-Jansen AM et al (2004) Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 41:109-116
17. Bieche I, Lidreau R (2000) Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Mol Carcinog 29(3):151-158
18. Lukas J et al (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506
19. Seitz S et al (2001) Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. J Pathol 194:318-326
20. Winqvist R et al (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55(12):2660-2664